New Drug Boosts Response in Primary Biliary Cirrhosis (CME/CE)

(MedPage Today) -- Called obeticholic acid, the investigational agent is a farnesoid X receptor agonist.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news